 | • レポートコード：D0GIR-02099 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、皮膚科用OTC薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。皮膚科用OTC薬の種類別市場規模（抗真菌薬、皮膚消毒薬、皮膚刺激薬、創傷・単純ヘルペス薬、抗乾癬薬、その他）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Aurobindo、Johnson & Johnson、GSK、Sun Pharmaceutical、Teva、CR SANJIU、Mylan、Novartis、Galderma、Livzon、Dr. Reddy's、Almirall、Cipla、Lupin、Lingrui、Bausch Health ・地域別グローバル市場分析 2015年-2020年 ・皮膚科用OTC薬の北米市場（アメリカ、カナダ、メキシコ） ・皮膚科用OTC薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮膚科用OTC薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮膚科用OTC薬の南米市場（ブラジル、アルゼンチン） ・皮膚科用OTC薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗真菌薬、皮膚消毒薬、皮膚刺激薬、創傷・単純ヘルペス薬、抗乾癬薬、その他 ・用途別分析：病院、薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Dermatology OTC Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Dermatology OTC Drug sales will be xx in 2020 from Dermatology OTC Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Dermatology OTC Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Dermatology OTC Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Dermatology OTC Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Dermatology OTC Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dermatology OTC Drug market has been segmented into:
Antifungals Medication
Skin Disinfection Medication
Skin Irritation Medication
Wounds and Herpes Simplex Medication
Anti-Psoriasis Medication
Other
By Application, Dermatology OTC Drug has been segmented into:
Hospital
Drug Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermatology OTC Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermatology OTC Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermatology OTC Drug market.
The report offers in-depth assessment of the growth and other aspects of the Dermatology OTC Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Dermatology OTC Drug Market Share Analysis
Dermatology OTC Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermatology OTC Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermatology OTC Drug sales, revenue and market share for each player covered in this report.
The major players covered in Dermatology OTC Drug are:
Bayer
Aurobindo
Johnson & Johnson
GSK
Sun Pharmaceutical
Teva
CR SANJIU
Mylan
Novartis
Galderma
Livzon
Dr. Reddy’s
Almirall
Cipla
Lupin
Lingrui
Bausch Health
Among other players domestic and global, Dermatology OTC Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Dermatology OTC Drug Market Overview
1.1 Product Overview and Scope of Dermatology OTC Drug
1.2 Classification of Dermatology OTC Drug by Type
1.2.1 Global Dermatology OTC Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Dermatology OTC Drug Revenue Market Share by Type in 2019
1.2.3 Antifungals Medication
1.2.4 Skin Disinfection Medication
1.2.5 Skin Irritation Medication
1.2.6 Wounds and Herpes Simplex Medication
1.2.7 Anti-Psoriasis Medication
1.2.8 Other
1.3 Global Dermatology OTC Drug Market by Application
1.3.1 Overview: Global Dermatology OTC Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Dermatology OTC Drug Market by Regions
1.4.1 Global Dermatology OTC Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Dermatology OTC Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Dermatology OTC Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Dermatology OTC Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dermatology OTC Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Dermatology OTC Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dermatology OTC Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Dermatology OTC Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Dermatology OTC Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Dermatology OTC Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aurobindo
2.2.1 Aurobindo Details
2.2.2 Aurobindo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aurobindo SWOT Analysis
2.2.4 Aurobindo Product and Services
2.2.5 Aurobindo Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sun Pharmaceutical SWOT Analysis
2.5.4 Sun Pharmaceutical Product and Services
2.5.5 Sun Pharmaceutical Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva SWOT Analysis
2.6.4 Teva Product and Services
2.6.5 Teva Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 CR SANJIU
2.7.1 CR SANJIU Details
2.7.2 CR SANJIU Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CR SANJIU SWOT Analysis
2.7.4 CR SANJIU Product and Services
2.7.5 CR SANJIU Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan SWOT Analysis
2.8.4 Mylan Product and Services
2.8.5 Mylan Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Galderma
2.10.1 Galderma Details
2.10.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Galderma SWOT Analysis
2.10.4 Galderma Product and Services
2.10.5 Galderma Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Livzon
2.11.1 Livzon Details
2.11.2 Livzon Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Livzon SWOT Analysis
2.11.4 Livzon Product and Services
2.11.5 Livzon Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dr. Reddy’s
2.12.1 Dr. Reddy’s Details
2.12.2 Dr. Reddy’s Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Dr. Reddy’s SWOT Analysis
2.12.4 Dr. Reddy’s Product and Services
2.12.5 Dr. Reddy’s Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 Almirall
2.13.1 Almirall Details
2.13.2 Almirall Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Almirall SWOT Analysis
2.13.4 Almirall Product and Services
2.13.5 Almirall Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Cipla SWOT Analysis
2.14.4 Cipla Product and Services
2.14.5 Cipla Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.15 Lupin
2.15.1 Lupin Details
2.15.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Lupin SWOT Analysis
2.15.4 Lupin Product and Services
2.15.5 Lupin Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.16 Lingrui
2.16.1 Lingrui Details
2.16.2 Lingrui Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Lingrui SWOT Analysis
2.16.4 Lingrui Product and Services
2.16.5 Lingrui Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bausch Health
2.17.1 Bausch Health Details
2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bausch Health SWOT Analysis
2.17.4 Bausch Health Product and Services
2.17.5 Bausch Health Dermatology OTC Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Dermatology OTC Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Dermatology OTC Drug Players Market Share
3.2.2 Top 10 Dermatology OTC Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Dermatology OTC Drug Revenue and Market Share by Regions
4.2 North America Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
4.5 South America Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
5 North America Dermatology OTC Drug Revenue by Countries
5.1 North America Dermatology OTC Drug Revenue by Countries (2015-2020)
5.2 USA Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
6 Europe Dermatology OTC Drug Revenue by Countries
6.1 Europe Dermatology OTC Drug Revenue by Countries (2015-2020)
6.2 Germany Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
6.3 UK Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
6.4 France Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Dermatology OTC Drug Revenue by Countries
7.1 Asia-Pacific Dermatology OTC Drug Revenue by Countries (2015-2020)
7.2 China Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
7.5 India Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
8 South America Dermatology OTC Drug Revenue by Countries
8.1 South America Dermatology OTC Drug Revenue by Countries (2015-2020)
8.2 Brazil Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Dermatology OTC Drug by Countries
9.1 Middle East & Africa Dermatology OTC Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Dermatology OTC Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Dermatology OTC Drug Market Forecast by Type (2019-2024)
10.3 Antifungals Medication Revenue Growth Rate (2015-2025)
10.4 Skin Disinfection Medication Revenue Growth Rate (2015-2025)
10.5 Skin Irritation Medication Revenue Growth Rate (2015-2025)
10.6 Wounds and Herpes Simplex Medication Revenue Growth Rate (2015-2025)
10.7 Anti-Psoriasis Medication Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global Dermatology OTC Drug Market Segment by Application
11.1 Global Dermatology OTC Drug Revenue Market Share by Application (2015-2020)
11.2 Dermatology OTC Drug Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug Store Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Dermatology OTC Drug Market Size Forecast (2021-2025)
12.1 Global Dermatology OTC Drug Market Size Forecast (2021-2025)
12.2 Global Dermatology OTC Drug Market Forecast by Regions (2021-2025)
12.3 North America Dermatology OTC Drug Revenue Market Forecast (2021-2025)
12.4 Europe Dermatology OTC Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Dermatology OTC Drug Revenue Market Forecast (2021-2025)
12.6 South America Dermatology OTC Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Dermatology OTC Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Dermatology OTC Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dermatology OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dermatology OTC Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Dermatology OTC Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Dermatology OTC Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bayer Corporate Information, Location and Competitors
Table 7. Bayer Dermatology OTC Drug Major Business
Table 8. Bayer Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 9. Bayer SWOT Analysis
Table 10. Bayer Dermatology OTC Drug Product and Solutions
Table 11. Bayer Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Aurobindo Corporate Information, Location and Competitors
Table 13. Aurobindo Dermatology OTC Drug Major Business
Table 14. Aurobindo Dermatology OTC Drug Total Revenue (USD Million) (2018-2019)
Table 15. Aurobindo SWOT Analysis
Table 16. Aurobindo Dermatology OTC Drug Product and Solutions
Table 17. Aurobindo Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Johnson & Johnson Corporate Information, Location and Competitors
Table 19. Johnson & Johnson Dermatology OTC Drug Major Business
Table 20. Johnson & Johnson Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 21. Johnson & Johnson SWOT Analysis
Table 22. Johnson & Johnson Dermatology OTC Drug Product and Solutions
Table 23. Johnson & Johnson Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. GSK Corporate Information, Location and Competitors
Table 25. GSK Dermatology OTC Drug Major Business
Table 26. GSK Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 27. GSK SWOT Analysis
Table 28. GSK Dermatology OTC Drug Product and Solutions
Table 29. GSK Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 31. Sun Pharmaceutical Dermatology OTC Drug Major Business
Table 32. Sun Pharmaceutical Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 33. Sun Pharmaceutical SWOT Analysis
Table 34. Sun Pharmaceutical Dermatology OTC Drug Product and Solutions
Table 35. Sun Pharmaceutical Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Teva Corporate Information, Location and Competitors
Table 37. Teva Dermatology OTC Drug Major Business
Table 38. Teva Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 39. Teva SWOT Analysis
Table 40. Teva Dermatology OTC Drug Product and Solutions
Table 41. Teva Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CR SANJIU Corporate Information, Location and Competitors
Table 43. CR SANJIU Dermatology OTC Drug Major Business
Table 44. CR SANJIU Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 45. CR SANJIU SWOT Analysis
Table 46. CR SANJIU Dermatology OTC Drug Product and Solutions
Table 47. CR SANJIU Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Mylan Corporate Information, Location and Competitors
Table 49. Mylan Dermatology OTC Drug Major Business
Table 50. Mylan Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 51. Mylan SWOT Analysis
Table 52. Mylan Dermatology OTC Drug Product and Solutions
Table 53. Mylan Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Novartis Corporate Information, Location and Competitors
Table 55. Novartis Dermatology OTC Drug Major Business
Table 56. Novartis Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 57. Novartis SWOT Analysis
Table 58. Novartis Dermatology OTC Drug Product and Solutions
Table 59. Novartis Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Galderma Corporate Information, Location and Competitors
Table 61. Galderma Dermatology OTC Drug Major Business
Table 62. Galderma Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 63. Galderma SWOT Analysis
Table 64. Galderma Dermatology OTC Drug Product and Solutions
Table 65. Galderma Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Livzon Corporate Information, Location and Competitors
Table 67. Livzon Dermatology OTC Drug Major Business
Table 68. Livzon Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 69. Livzon SWOT Analysis
Table 70. Livzon Dermatology OTC Drug Product and Solutions
Table 71. Livzon Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Dr. Reddy's Corporate Information, Location and Competitors
Table 73. Dr. Reddy's Dermatology OTC Drug Major Business
Table 74. Dr. Reddy's Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 75. Dr. Reddy's SWOT Analysis
Table 76. Dr. Reddy's Dermatology OTC Drug Product and Solutions
Table 77. Dr. Reddy's Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Almirall Corporate Information, Location and Competitors
Table 79. Almirall Dermatology OTC Drug Major Business
Table 80. Almirall Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 81. Almirall SWOT Analysis
Table 82. Almirall Dermatology OTC Drug Product and Solutions
Table 83. Almirall Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Cipla Corporate Information, Location and Competitors
Table 85. Cipla Dermatology OTC Drug Major Business
Table 86. Cipla Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 87. Cipla SWOT Analysis
Table 88. Cipla Dermatology OTC Drug Product and Solutions
Table 89. Cipla Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Lupin Corporate Information, Location and Competitors
Table 91. Lupin Dermatology OTC Drug Major Business
Table 92. Lupin Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 93. Lupin SWOT Analysis
Table 94. Lupin Dermatology OTC Drug Product and Solutions
Table 95. Lupin Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Lingrui Corporate Information, Location and Competitors
Table 97. Lingrui Dermatology OTC Drug Major Business
Table 98. Lingrui Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 99. Lingrui SWOT Analysis
Table 100. Lingrui Dermatology OTC Drug Product and Solutions
Table 101. Lingrui Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Bausch Health Corporate Information, Location and Competitors
Table 103. Bausch Health Dermatology OTC Drug Major Business
Table 104. Bausch Health Dermatology OTC Drug Total Revenue (USD Million) (2017-2018)
Table 105. Bausch Health SWOT Analysis
Table 106. Bausch Health Dermatology OTC Drug Product and Solutions
Table 107. Bausch Health Dermatology OTC Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Dermatology OTC Drug Revenue (Million USD) by Players (2015-2020)
Table 109. Global Dermatology OTC Drug Revenue Share by Players (2015-2020)
Table 110. Global Dermatology OTC Drug Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Dermatology OTC Drug Revenue Market Share by Regions (2015-2020)
Table 112. North America Dermatology OTC Drug Revenue by Countries (2015-2020)
Table 113. North America Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Table 114. Europe Dermatology OTC Drug Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Dermatology OTC Drug Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Dermatology OTC Drug Revenue by Countries (2015-2020)
Table 117. South America Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Dermatology OTC Drug Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Table 120. Global Dermatology OTC Drug Revenue (Million USD) by Type (2015-2020)
Table 121. Global Dermatology OTC Drug Revenue Share by Type (2015-2020)
Table 122. Global Dermatology OTC Drug Revenue Forecast by Type (2021-2025)
Table 123. Global Dermatology OTC Drug Revenue by Application (2015-2020)
Table 124. Global Dermatology OTC Drug Revenue Share by Application (2015-2020)
Table 125. Global Dermatology OTC Drug Revenue Forecast by Application (2021-2025)
Table 126. Global Dermatology OTC Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Dermatology OTC Drug Picture
Figure 2. Global Dermatology OTC Drug Revenue Market Share by Type in 2019
Figure 3. Antifungals Medication Picture
Figure 4. Skin Disinfection Medication Picture
Figure 5. Skin Irritation Medication Picture
Figure 6. Wounds and Herpes Simplex Medication Picture
Figure 7. Anti-Psoriasis Medication Picture
Figure 8. Other Picture
Figure 9. Dermatology OTC Drug Revenue Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Drug Store Picture
Figure 12. Other Picture
Figure 13. Global Dermatology OTC Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Dermatology OTC Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Dermatology OTC Drug Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Dermatology OTC Drug Revenue Market Share in 2019
Figure 22. Global Top 10 Players Dermatology OTC Drug Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Dermatology OTC Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Dermatology OTC Drug Revenue Market Share by Regions (2015-2020)
Figure 26. Global Dermatology OTC Drug Revenue Market Share by Regions in 2018
Figure 27. North America Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 28. Europe Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 30. South America Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 32. North America Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 33. North America Dermatology OTC Drug Revenue Market Share by Countries in 2019
Figure 34. USA Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 35. Canada Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 37. Europe Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Dermatology OTC Drug Revenue Market Share by Countries in 2019
Figure 39. Germany Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 40. UK Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 41. France Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 42. Russia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 43. Italy Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Dermatology OTC Drug Revenue Market Share by Countries in 2019
Figure 46. China Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 47. Japan Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 48. Korea Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 49. India Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 51. South America Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 52. South America Dermatology OTC Drug Revenue Market Share by Countries in 2019
Figure 53. Brazil Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Dermatology OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Dermatology OTC Drug Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 58. UAE Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Dermatology OTC Drug Revenue and Growth Rate (2015-2020)
Figure 61. Global Dermatology OTC Drug Revenue Share by Type (2015-2020)
Figure 62. Global Dermatology OTC Drug Revenue Share by Type in 2019
Figure 63. Global Dermatology OTC Drug Market Share Forecast by Type (2021-2025)
Figure 64. Global Antifungals Medication Revenue Growth Rate (2015-2020)
Figure 65. Global Skin Disinfection Medication Revenue Growth Rate (2015-2020)
Figure 66. Global Skin Irritation Medication Revenue Growth Rate (2015-2020)
Figure 67. Global Wounds and Herpes Simplex Medication Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-Psoriasis Medication Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Dermatology OTC Drug Revenue Share by Application (2015-2020)
Figure 71. Global Dermatology OTC Drug Revenue Share by Application in 2019
Figure 72. Global Dermatology OTC Drug Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Revenue Growth Rate (2015-2020)
Figure 74. Global Drug Store Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Dermatology OTC Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Dermatology OTC Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Dermatology OTC Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Dermatology OTC Drug Revenue Market Forecast (2021-2025)
Figure 80. Europe Dermatology OTC Drug Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Dermatology OTC Drug Revenue Market Forecast (2021-2025)
Figure 82. South America Dermatology OTC Drug Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Dermatology OTC Drug Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
皮膚科用カニューレの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Dermatology Cannula market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 皮膚科用医療機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Dermatology Medical Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 痤瘡治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acne Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7718.3 million by 2025, from USD 7098.1 million in 2019. The Acne Medication mark…
- 注射型鎮痛薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Injectable Pain Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 市販用鎮痛剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Over-the-Counter Pain Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Over-the-Cou…